WHO Prequalifies First Approved Ebola Vaccine As Rollout Of Experimental Vaccine Begins In DRC; Security Issues Continue To Challenge Response, WHO Says

ABC News: Ervebo approved as 1st Ebola vaccine
“The world’s first Ebola vaccine is finally approved, a critical move that opens the door for its use in countries at high risk for the infectious disease. Just 48 hours after the European Commission granted marketing authorization for the vaccine, the World Health Organization (WHO) announced Tuesday that it had also pre-qualified the vaccine, meaning it meets the WHO’s quality, safety, and efficacy standards…” (Schumaker, 11/13).

Reuters: Rollout of Johnson & Johnson Ebola vaccine begins in Congo
“Health authorities in eastern Congo have introduced a new Ebola vaccine produced by Johnson & Johnson, aid group MSF said on Thursday, to help combat the world’s second-worst outbreak of the virus on record. … The new vaccine, which has passed clinical trials but has never been tested in a real-world setting, will be administered to 50,000 people in Goma, a city of two million on the Rwandan border, Médecins Sans Frontières (MSF) said in a statement…” (Mahamba/Holland, 11/14).

VOA: Security Stymies Effort to End Ebola in Congo
“The World Health Organization says that dangers posed by armed groups in two eastern Democratic Republic of Congo provinces are impeding progress in the battle to stop the spread of the deadly Ebola virus. Latest reports put the number of confirmed Ebola cases at 3,287, including 2,193 deaths…” (Schlein, 11/13).

Additional coverage of the Ebola outbreak and response is available from Al Jazeera, BBC, CIDRAP News, Homeland Preparedness News, UPI, and Xinhua.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.